Zhiming Li

34PUBLICATIONS
153CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Oct 22, 2026
ROR2-expressing acute myelogenous leukemia cells can be selectively targeted by anti-ROR2 CAR T cells.

|Oct 20, 2026
A multicentre phase III clinical trial of dual-epigenetic therapy plus CHOP compared with CHOP in previously untreated patients with peripheral T-cell lymphoma.

|Mar 28, 2026
Zanubrutinib-rituximab followed by shortened chemoimmunotherapy as frontline treatment for mantle cell lymphoma (CHESS): a phase II trial.

Yuchen Zhang, Man Nie, Yi Cao

|Mar 17, 2026
Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinion.

Won Seog Kim, Mubarak Al Mansour, Chan Cheah

|Jan 28, 2026
Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Multicenter, Phase IIa Trial.

Liqiong Xue, Yaqian Han, Qingyuan Zhang

|Jul 24, 2025
Cadonilimab (a PD-1/CTLA-4 Bispecific Antibody) plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase II Clinical Trial.

Fei Cao, Yan Li, Qi Fang

Pageof 6

Frequent Collaborators

5 joint publications

Panpan Liu

5 joint publications

Qingqing Cai

4 joint publications

Keshu Zhou

4 joint publications

Wei Zhang